Michelle V Chan, OD
Optometry · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Milpitas Optometric Group · 6 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chan’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G35016 · Cancelled
Licence status: Cancelled · since 1977 · University of Washington School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,014
Medicare paid this office $3,014 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 13 | $1,223 | $87 |
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 74 · Health risk score 0.85. At or below the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 58%.
The office billed $5,558, Medicare allowed $4,859 and paid $3,014; for 40 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 40 | 74 | 0.85 | $5,558 | $3,014 |
| 2023 | 27 | 38 | 74 | 0.85 | $4,437 | $2,324 |
| 2022 | 13 | 17 | 75 | 0.67 | $1,949 | $1,282 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Money from drug and device companies
$869 in 2025
| 2025 | 7 | 15 | None | $869 |
| 2024 | 3 | 8 | None | $315 |
| 2023 | 4 | 6 | None | $160 |
| 2022 | 1 | 1 | None | $100 |
| 2021 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Johnson & Johnson Vision Care | Acuvue | $364 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $168 | 3 payments
|
| Visioneering Technologies | None | $164 | 1 payment
|
| CooperVision | Paragon Crt | $62 | 2 payments
|
| Alcon Vision | Dailies Total1 | $62 | 3 payments
|
| Bausch & Lomb Americas | Infuse | $25 | 1 payment
|
See all 15 published payments
| Sun Pharmaceutical Industries | Meals · 2025-12-02 | Cequa | $14 |
| Optos | Entertainment · 2025-11-17 | Nfc-700 | $24 |
| Alcon Vision | Meals · 2025-11-10 | Dailies Total1 | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-10-29 | Cequa | $31 |
| Alcon Vision | Meals · 2025-09-19 | Precision7 | $16 |
| Johnson & Johnson Vision Care | Meals · 2025-08-27 | None | $32 |
| Sun Pharmaceutical Industries | Meals · 2025-07-30 | Cequa | $124 |
| Johnson & Johnson Vision Care | Meals · 2025-06-30 | Acuvue | $125 |
| Johnson & Johnson Vision Care | Meals · 2025-06-25 | None | $173 |
| CooperVision | Meals · 2025-04-30 | Myday Contact Lens | $28 |
| Alcon Vision | Meals · 2025-04-16 | Dailies Total1 | $21 |
| Bausch & Lomb Americas | Meals · 2025-03-17 | Infuse | $25 |
| Visioneering Technologies | Meals · 2025-03-12 | None | $164 |
| Johnson & Johnson Vision Care | Meals · 2025-01-15 | None | $34 |
| CooperVision | Meals · 2025-01-08 | Paragon Crt | $34 |
See earlier years (2024, 2023, 2022, 2021)
2024: $315
| Johnson & Johnson Vision Care | None | $271 | 6 payments
|
| Optos | Nfc-700 | $25 | 1 payment
|
| Bausch & Lomb Americas | Infuse | $19 | 1 payment
|
2023: $160
| Bausch & Lomb Americas | Infuse | $56 | 2 payments
|
| Johnson & Johnson Vision Care | Acuvue | $48 | 2 payments
|
| CooperVision | Myday Contact Lens | $28 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $27 | 1 payment
|
2022: $100
| Oyster Point Pharma | Tyrvaya | $100 | 1 payment
|
2021: $19
| Bausch & Lomb a division of Bausch Health US | Infuse | $19 | 1 payment
|
Professional record
- NPI
- 1124697818
- Licence
- CA 35016California G35016: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 1751 Aprilsong Ct, San Jose, CA, 95131
- NPI first listed
- 2021-06-18
- NPI last updated
- 2021-09-30
- NPI record certified
- 2021-09-30
This is when the NPI record was last certified, not a medical board exam.